Shares of ProKidney rose 558% after it reported favorable results from a study of its lead drug candidate, rilparencel, in patients with chronic kidney disease and diabetes.

Shares in drug companies such as Eli Lilly dropped from their session highs Tuesday afternoon after President Donald Trump said U.S. tariffs on imported pharmaceuticals could be as high as 200%.

The agency cut its 2026 Brent price estimate to $58 a barrel from $59 previously. The EIA sees West Texas Intermediate crude, the U.S. benchmark, averaging $65 a barrel this year and $55 in 2026, ...

Tuesday's $58 billion sale of 3-year Treasury notes was met with below-average bidding by nondealers, a sign of waning investor demand since President Donald Trump's budget megabill was signed into ...

President Donald Trump said Tuesday that his administration was “probably two days off” from sending a letter with a tariff rate to the European Union, after the 27-nation bloc wasn’t among the 14 U.S ...